Status:
SUSPENDED
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
Lead Sponsor:
Dr. Alexander Supady
Collaborating Sponsors:
Klinikum Ibbenbüren
Ludwig-Maximilians - University of Munich
Conditions:
Coronavirus Infection
COVID
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
In December 2019 in the city of Wuhan in China, a series of patients with unclear pneumonia was noticed, some of whom have died of it. In virological analyses of samples from the patients' deep respir...
Detailed Description
In December 2019, a series of unexplained cases of pneumonia in the city of Wuhan in China has come to light. In virologic analyses of samples from the patients' deep respiratory tract, a novel corona...
Eligibility Criteria
Inclusion
- SARS-CoV-2-infection with COVID-pneumonia
- vv-ECMO therapy
Exclusion
- known patient will against participation in the study or against the measures applied in the study
- a decision (made prior to inclusion of the patient into this trial) to terminate the treatment within the next 24 hours
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04385771
Start Date
September 1 2020
End Date
October 31 2021
Last Update
March 15 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Freiburg
Freiburg im Breisgau, Germany, 79106
2
Klinikum Ibbenbueren
Ibbenbueren, Germany, 49477
3
Klinikum Ludwigsburg
Ludwigsburg, Germany